Inventor · disambiguated record
Emanuele Gabellieri
Also filed as: GABELLIERI EMANUELE
13 granted patents·17 pending applications·5 citations·filing 2009–2023
83Inventor score
Files withAC IMMUNE SA18ANDREINI MATTEO3HOFFMANN LA ROCHE3TEVA PHARMA2TEVA PHARMACEUTICAL INDUSTRIES LTD2
Top patents by PatentIndex Score
30 records- 0173US8815881B21,4,5,6-tetrahydro-pyrimidin-2-ylamine compoundsBANNER DAVID·Filed 2011·Granted Aug 26, 2014·1 cites·14 claims
- 0272US2024051967A1Bicyclic compounds for diagnosis and therapyAC IMMUNE SA·Filed 2023·Application pending·0 cites
- 0368US2022402875A1S1P3 AntagonistsTEVA PHARMA·Filed 2022·Application pending·0 cites
- 0467US10662193B2Carbazole and carboline compounds for use in the diagnosis, treatment, alleviation or prevention of disorders associated with amyloid or amyloid-like proteinsAC IMMUNE SA·Filed 2015·Granted May 26, 2020·1 cites·14 claims
- 0567US2023255976A1Novel Compounds for the Treatment, Alleviation or Prevention of Disorders Associated with Tau AggregatesAC IMMUNE SA·Filed 2023·Application pending·0 cites
- 0666US8748418B21,4-oxazepines as BACE1 and/or BACE2 inhibitorsGABELLIERI EMANUELE·Filed 2012·Granted Jun 10, 2014·2 cites·28 claims
- 0762US11684625B2Compounds for the treatment, alleviation or prevention of disorders associated with tau aggregatesAC IMMUNE SA·Filed 2019·Granted Jun 27, 2023·0 cites·12 claims
- 0861US9951017B2S1P3 antagonistsTEVA PHARMACEUTICAL INDUSTRIES LTD·Filed 2014·Granted Apr 24, 2018·1 cites·22 claims
- 0960US2014336208A11,4,5,6-tetrahydro-pyrimidin-2-ylamine compoundsHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 1059US11472772B2S1P3 antagonistsTEVA PHARMA·Filed 2020·Granted Oct 18, 2022·0 cites·20 claims
- 1158US11623931B2Bicyclic compounds for diagnosis and therapyAC IMMUNE SA·Filed 2020·Granted Apr 11, 2023·0 cites·10 claims
- 1256US11814378B2Compounds for the treatment, alleviation or prevention of disorders associated with Tau aggregatesAC IMMUNE SA·Filed 2020·Granted Nov 14, 2023·0 cites·32 claims
- 1355US10835624B2Compounds for imaging Tau protein aggregatesAC IMMUNE SA·Filed 2017·Granted Nov 17, 2020·0 cites·14 claims
- 1452US2013196984A13-amino-5-phenyl-56-dihydro-2h-[1,4]oxazinesHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 1551US2025109126A1Dihydro-oxazol derivative compoundsAC IMMUNE SA·Filed 2022·Application pending·0 cites
- 1648US12202840B2Compounds for the treatment or alleviation of disorders associated with Tau aggregatesAC IMMUNE SA·Filed 2019·Granted Jan 21, 2025·0 cites·13 claims
- 1748US7989449B24,5-dihydro-oxazol-2-yl amine derivativesHOFFMANN LA ROCHE·Filed 2009·Granted Aug 2, 2011·0 cites·18 claims
- 1848US2018201582A1S1p3 antagonistsTEVA PHARMACEUTICAL INDUSTRIES LTD·Filed 2018·Application pending·0 cites
- 1948US2019071450A1Bicyclic compounds for diagnosis and therapyAC IMMUNE SA·Filed 2017·Application pending·0 cites
- 2048US2022378801A1Novel compoundsAC IMMUNE SA·Filed 2020·Application pending·0 cites
- 2147US2023250070A1Dihydrooxazole and thiourea derivatives modulating the nlrp3 inflammasome pathwayAC IMMUNE SA·Filed 2021·Application pending·0 cites
- 2247US2012214806A13-amino-5-phenyl-5,6-dihydro-2h-[1,4]oxazinesANDREINI MATTEO·Filed 2012·Application pending·0 cites
- 2346US2022127263A1Novel Compounds for the Treatment, Alleviation or Prevention of Disorders Associated with Tau AggregatesAC IMMUNE SA·Filed 2020·Application pending·0 cites
- 2446US2021041447A1Azacarboline compounds for the detection of tau aggregatesAC IMMUNE SA·Filed 2019·Application pending·0 cites
- 2546US2023391774A1Novel CompoundsAC IMMUNE SA·Filed 2021·Application pending·0 cites
- 2646US2021047327A1Diagnostic compositions for pet imaging, a method for manufacturing the diagnostic composition and its use in diagnosticsAC IMMUNE SA·Filed 2019·Application pending·0 cites
- 2740US2021038747A1Novel method of preparing an imaging compoundAC IMMUNE SA·Filed 2019·Application pending·0 cites
- 2835US9242943B21,4 oxazines as BACE1 and/or BACE2 inhibitorsANDREINI MATTEO·Filed 2012·Granted Jan 26, 2016·0 cites·17 claims
- 2934US2018264146A1Novel imaging compoundsAC IMMUNE SA·Filed 2016·Application pending·0 cites
- 3033US8399459B21,4 oxazines as BACE1 and/or BACE2 inhibitorsANDREINI MATTEO·Filed 2012·Granted Mar 19, 2013·0 cites·25 claims
Join the waitlist — get patent alerts
Get an alert when Emanuele Gabellieri files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →